This project is based on Kauaʻi, where the Maui-based Pacific Biodiesel last year began supplying its biodiesel to KIUC as a source of renewable energy supporting the Kauaʻi utility’s accelerated pathway to 100% renewable electricity production by 2033, more than a decade earlier than the State of Hawaiʻi’s mandated timeline of 2045.
How the vaccine is hurting production of other drugs • Pritzker signs equity-driven hospital transformation plan • When will we reach herd immunity? chicagobusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagobusiness.com Daily Mail and Mail on Sunday newspapers.
Horizon
Horizon in December announced it would delay new patients from starting Tepezza treatment to conserve supply for existing users.
Invoking the Defense Production Act is helping increase supply of badly needed COVID-19 vaccines, bringing the U.S. one step closer to ending the pandemic but as one local drug company has learned, there s a catch.
The government mandate to prioritize vaccine production at a biologics manufacturing facility has led to a shortage of Horizon Therapeutics top-selling product, a new remedy for thyroid eye disease. Tepezza was on track for $850 million in sales last year, until contract manufacturer Catalent was forced to stop making the intravenous drug.